To include your compound in the COVID-19 Resource Center, submit it here.

Gene therapy play Audentes raises $42.5M

Audentes Therapeutics Inc. (San Francisco, Calif.) raised $42.5 million in a series B round

Read the full 140 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE